spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Retinitis 

 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 3 Jul 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 30 Jan 2023
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 18 Apr 2022
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2022
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration
Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 23 Feb 2021
PYC Therapeutics Expands U.S. Executive Leadership Team with the Appointment of Glenn Noronha, PhD, as Chief Development Officer
Biopharmaceutical Drug Delivery Personnel
 HSMN NewsFeed - 17 Jul 2020
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 May 2019
ReNeuron Provides Business Update and Results Notification
Regenerative Medicine Ophthalmology Neurology
 HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2018
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 19 Jun 2017
Ocugen Makes Strategic Appointments to Management Team
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 18 Nov 2016
AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2016
Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS(R)II Bionic Vision System
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 5 May 2016
Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2016
Pixium Vision Implants IRIS(R) II, First Epi-Retinal Implant with 150 Electrodes
Devices Ophthalmology
 HSMN NewsFeed - 5 Feb 2016
Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Nov 2015
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 22 Jul 2015
Second Sight Announces First Age-Related Macular Degeneration Patient Receives the Argus II Retinal Prosthesis System as Part of Groundbreaking Study
Devices Ophthalmology
 HSMN NewsFeed - 5 Mar 2015
Second Sight Announces Successful First Implants of the Argus(R) II Retinal Prosthesis System at Two New Centers in Italy
Devices Ophthalmology
 HSMN NewsFeed - 15 Sep 2014
Retina Implant AG's International Clinical Results Presented for the First Time in Europe
Devices Ophthalmology
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 29 Jan 2014
Second Sight Announces First Commercial Implants of the Argus(R) II Retinal Prosthesis System in the United States
Devices Ophthalmology
 HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 3 Jul 2013
Retina Implant AG's Alpha IMS Wins CE Mark
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 1 Oct 2012
FDA Panel Recommends FDA Approval for Second Sight’s Argus(R) II Retinal Prosthesis System
Devices Ophthalmology FDA
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 19 Apr 2012
RetroSense Welcomes Dr. Peter Francis as Clinical Director
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Feb 2012
Results from International Trial of Second Sight’s Argus(R) II Retinal Prosthesis System Published in Ophthalmology
Devices Ophthalmology
 HSMN NewsFeed - 21 Nov 2011
Retina Implant AG Gains Unanimous Scientific Advisory Board Approval To Expand Clinical Trial Across Europe
Devices Ophthalmology
 HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2011
Retina Implant AG Secures $18 Million in Second Round of Venture Capital Funding
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 15 Oct 2010
FDA Approves H.P. Acthar(R) Gel for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Apr 2010
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 18 Nov 2009
StemCells, Inc. Provides Update on NCL Program Meeting with FDA
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 31 Aug 2009
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 May 2009
Ophthonix Completes Series AA Financing at $25.9 Million
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 5 May 2009
Breakthrough Medical Device Gives Hope for Blindness-Related Diseases
Devices Ophthalmology
 HSMN NewsFeed - 13 Feb 2009
IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 2 Feb 2009
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Sep 2008
Neurotech Granted Fast Track Designations from the FDA for NT-501 in Two Indications - Retinitis Pigmentosa and Dry Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 12 Dec 2007
Fovea Pharmaceuticals Completes EUR30M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Aug 2007
Neurotech Names Richard Small Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 18 Jul 2007
pSivida Strengthens its Position in Drug Delivery Sector
Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 1 May 2007
pSivida Announces Board Change
Biopharmaceuticals Ophthalmology Drug Delivery Personnel
 HSMN NewsFeed - 17 Apr 2007
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
Biopharmaceuticals Ophthalmology Drug Delivery Licensing
 HSMN NewsFeed - 27 Mar 2007
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2007
pSivida Announcement: RetisertTM Drug Implant Receives Product Specific Bill Code and Medicare Reimbursement Rate
Biopharmaceuticals Ophthalmology Reimbursement
 HSMN NewsFeed - 24 Jan 2007
pSivida appoints Boston based Managing Director
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Dec 2006
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Dec 2006
Ophthonix Completes Series D Financing at $35.1 Million
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 16 Nov 2006
Neurotech(TM), Inc. Completes $35 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Oct 2006
The Optobionics Pilot Clinical Study Shows Promising Vision Improvement for Retinitis Pigmentosa Patients
Devices Ophthalmology
 HSMN NewsFeed - 9 Oct 2006
First Patient Implanted in pSivida European Pancreatic Cancer Study
Devices Oncology
 HSMN NewsFeed - 25 May 2006
pSivida Provides Update on BrachySil(TM) Liver Program: Expansion of Multicenter Clinical Trial
Biopharmacetuicals Oncology Drug Delivery
Return to NewsFeed  

 Additional items found! 32

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 32 additional stories matching:
Retinitis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.